Prophecy (ASX:PRO) share price rockets 22% on major US health deal

The company's shares enjoyed a new 52-week high today…

| More on:
Businessman taking off in rocket-fuelled office chair

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Prophecy International Holdings Limited (ASX: PRO) share price is on the move this Thursday. The computer software applications and services company announced a major deal that has seen investors snapping up its shares.

At the time of writing, the Prophecy share price is up 22.41% to 71 cents. Earlier in the day, it hit a fresh 52-week high of 74.5 cents.

A huge win for Prophecy

In today's statement to the ASX, Prophecy advised it has signed a deal with United States-based health insurance company, Humana Inc (NYSE: HUM).

Founded in 1961, Humana is one of the biggest health insurance providers in the United States market. The company is ranked 41 on the Fortune 500 list, holding a market capitalisation of more than US$50 billion.

The deal will see Prophecy provide its software-as-a-service (SaaS) platform, eMite, to Humana for an initial 3-year period. This is expected to generate a minimum of $1.784 million in annualised recurring revenue (ARR), totalling $5.518 million.

eMite is a real time and historical customer experience and contact call centre analytics platform. The software product helps businesses visualise their customers' pathway and understand the level of happiness during the journey.

The innovative platform aims to assist large enterprise and government customers to maximise customer service and revenue opportunity.

Last year, eMite was sold in more than 14 countries to a range of customers in the Genesys, Amazon and Avaya ecosystems.

CEO Brad Thomas commented on the news fuelling the Prophecy share price:

We are delighted to welcome Humana as a new eMite customer. Given Humana's standing as one of the strongest participants in the US healthcare market, we are excited by the opportunity to strengthen Humana's ability to provide high-quality, whole-person healthcare and support superior outcomes for patients across all of its lines of business.

A contract of this nature is material to Prophecy as it, along with other recently-signed eMite customers, boost the annualised recurring revenue (ARR) for the eMite business to more than A$10 million. This growth reflects our continuous improvement of eMite's functionality as large enterprise and government have embraced cloud services.

Prophecy share price summary

Despite today's massive gain, the Prophecy share price mostly travelled in circles over the past 12 months. However, following the latest contract win, its shares are now up around 35% for the period.

Based on the current price, Prophecy presides a market capitalisation of roughly $49.35 million, with approximately 64 million shares outstanding.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Technology Shares

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Why is everyone talking about ResMed shares?

It’s been a good year for ResMed shareholders. Let’s find out why.

Read more »

rugby player scores touchdown
Technology Shares

Are Catapult shares still a buy after their 145% touchdown in 2024?

What do the experts think could be next?

Read more »

Excited group of friends sitting on sofa watching sports on TV and celebrating.
Technology Shares

Why today is a big day for Pro Medicus shares

Records are being broken by this share on Monday. What's going on?

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Technology Shares

Guess which ASX tech stock is jumping 13% amid 'financial transformation journey'

What is getting investors excited? Let's find out.

Read more »

An unhappy man in a suit sits at his desk with his arms crossed staring at his laptop screen as the PointsBet share price falls
Technology Shares

Should you buy WiseTech shares after the selloff?

Let's see what analysts are saying about this beaten down tech stock.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Technology Shares

Guess which ASX 200 tech stock could rise almost 40%

Goldman Sachs thinks that big returns could be coming for buyers of this stock.

Read more »

Man with rocket wings which have flames coming out of them.
Technology Shares

Guess which ASX All Ords share is rocketing 16% on an asset sale

This share is catching the eye with a very big gain on Friday. But why is it rising?

Read more »

a man clasps his hand to his forehead as he looks down at his phone and grimaces with a pained expression on his face as he watches the Pilbara Minerals share price continue to fall
Technology Shares

Why are Megaport shares sinking 14% on Friday?

Why are investors hitting the sell button? Let's find out.

Read more »